临床实践中测量脂蛋白(a)的意义。
The implications of measuring lipoprotein(a) in clinical practice.
作者信息
Barbir Mahmoud, Pottle Alison, Bornstein Stefan R
机构信息
Harefield Hospital, part of Guy's and St Thomas' NHS Foundation Trust, UK.
University Hospital Carl Gustav Carus Dresden, Fetscherstraße 74, 01307 Dresden, Germany.
出版信息
Glob Cardiol Sci Pract. 2024 Aug 1;2024(4):e202440. doi: 10.21542/gcsp.2024.40.
Lipoprotein(a) (Lp(a)) is a well-recognized causal risk factor for atherosclerotic cardiovascular disease (ASCVD) and calcific aortic valve stenosis. There are ongoing challenges with screening and management in primary and secondary prevention; however, future recommendations for clinical practice await the outcomes of clinical trials that are in progress.
脂蛋白(a)（Lp(a)）是动脉粥样硬化性心血管疾病（ASCVD）和钙化性主动脉瓣狭窄公认的因果风险因素。在一级和二级预防的筛查和管理方面仍存在挑战；然而，未来临床实践的建议有待正在进行的临床试验结果。
Zotero 插件